Andrea Friesen
Family Medicine · University Place, WANPI 1144232513
Payments from drug & device makers
Across 118 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$953
- Corcept Therapeutics$412
- Boehringer Ingelheim$154
- Merz North America, Inc.$142
- Lundbeck LLC$123
- Novo Nordisk$122
- plus $976 from 17 others
What the payments were for
- Food & beverage$2,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $953 |
| Corcept Therapeutics | 12 | $412 |
| Boehringer Ingelheim | 9 | $154 |
| Merz North America, Inc. | 3 | $142 |
| Lundbeck LLC | 4 | $123 |
| Novo Nordisk | 6 | $122 |
| Phathom Pharmaceuticals, Inc. | 5 | $113 |
| Revance Therapeutics, Inc. | 1 | $95 |
| Dexcom, Inc. | 3 | $94 |
| Otsuka America Pharmaceutical, Inc. | 3 | $90 |
| Johnson & Johnson | 3 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $69 |
| Lilly USA, LLC | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Exact Sciences | 3 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $50 |
| Galderma Laboratories, L.p. | 2 | $48 |
| Alkermes, Inc. | 2 | $44 |
| AstraZeneca | 1 | $28 |
| Fidia Pharma USA Inc. | 1 | $28 |
| Abbott | 1 | $22 |
| Pfizer | 1 | $22 |
| Phadia US Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$135
How this compares
$2,881 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $795 |
| Levothyroxine Sodium | 46 | $476 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $420 |
| ProgesteroneProgesterone, Micronized | 12 | $292 |
| Rosuvastatin Calcium | 30 | $285 |
| Losartan Potassium | 15 | $207 |
| Atorvastatin Calcium | 19 | $202 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $190 |
| Clonazepam | 14 | $182 |
| Liothyronine Sodium | 11 | $154 |
| Lisinopril | 26 | $148 |
| Oxycodone Hcl | 16 | $148 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $144 |
| Pantoprazole Sodium | 13 | $111 |
| Amlodipine Besylate | 16 | $98 |
Paid to pharmacies, not to this prescriber.
Other family medicine in University Place
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
- Steven SmithAuburn$438K
- John RobinsonEdmonds$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.